CORDENPHARMA CHENÔVE (FR)

Core Capabilities

  • >> NCE cGMP custom synthesis from kilolab to multi tonne scale
  • >> Multi-step API process development, manufacturing and analytical development
  • >> Industrialization from feasibility to commercial scale
  • >> Regulatory filing in the US, EU and Japan
  • >> Pharmaceutical establishment in production of bulk pre-mixed drug products

COMPLIANCE

  • >> US FDA – 2016
  • >> ANSM – 2017
  • >> PMDA – 2015

Related Products & Platforms

Technology Platforms


Facility Legacy

CordenPharma Chenôve (formerly Synkem) is a cGMP manufacturer of APIs and advanced pharmaceutical intermediates specializing in synthetic route design and development.

As a former facility of Solvay Pharmaceuticals, CordenPharma Chenôve brings over 25 years of experience and expertise in pharmaceutical chemistry, technology, project management and registration processes to CordenPharma’s full-service CDMO platform.

HISTORY

  • >> 1960 MSD facility
  • >> 1985 Facility purchased by Fournier Laboratories
  • >> 1995 First FDA inspection
  • >> 2005 Fournier Laboratories taken over by Solvay Pharmaceuticals
  • >> 2008 Synkem acquired by ICIG
  • >> 2016 Synkem name changed to Corden Pharma Chenôve SAS
 

Managing Director

Yves Michon

Corden Pharma Chenôve SAS

47, rue de Longvic
B.P. 50
21301 Chenôve Cedex
France

Phone: +33 380 447 272
Fax: +33 380 447 270

Email Human Resources